Purple Footprints
Pancreatic Cancer Care: Promising Results of Investigational mRNA Vaccine
An investigational mRNA vaccine known as autogene cevumeran has demonstrated some potential in improving treatment outcomes for patients. The latest findings, presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, shed light on the promising immune response elicited by this innovative vaccine.
Read story ➞
Pancreatic Cancer Therapy Shows Promise
In a potentially interesting advance for pancreatic cancer patients, a new treatment has shown promising results when combined with various types of chemotherapy before surgery. A pilot study presented at American Association for Cancer Research’s (AACR) annual meeting unveiled encouraging findings that suggest improved outcomes for pancreatic cancer patients.
Read story ➞
PBAC reviews new treatment
Your opinion is required to help the Pharmaceutical Benefits Advisory Committee (PBAC) evaluate whether a new treatment should be funded for metastatic pancreatic cancer.
Read story ➞
PanKind - 2023 Year in Numbers
Our impact in 2023 is due to the support of our entire community. Thank you
Read story ➞